Deep Track Capital, LP Protagonist Therapeutics, Inc Transaction History

Deep Track Capital, LP

  • $2.71 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024
BUY
$14.05 - $23.44 $3.87 Million - $6.45 Million
275,201 New
275,201 $6.31 Million
Q4 2022

Feb 14, 2023
BUY
$7.36 - $11.17 $6.41 Million - $9.73 Million
871,493 New
871,493 $9.51 Million
Q4 2021

Feb 14, 2022
BUY
$17.63 - $37.1 $7.43 Million - $15.6 Million
421,660 New
421,660 $14.4 Million

Others Institutions Holding PTGX

# of Institutions
247
Shares Held
56.4M
Call Options Held
76.3K
Put Options Held
114K
View Full List

About Protagonist Therapeutics, Inc

PTGX Quotes by TradingView
  • Ticker PTGX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 49,084,100
  • Market Cap $2B
  • Description
  • Protagonist Therapeutics, Inc., a biopharmaceutical company, discovers and develops peptide-based therapeutic drugs to address hematology and blood disorders, and inflammatory and immunomodulatory diseases. It is developing rusfertide (PTG-300), an injectable hepcidin mimetic that is in Phase II clinical trials for the treatment of patients with...
More about PTGX
Track This Portfolio

Track Deep Track Capital, LP Portfolio

Follow Deep Track Capital, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Deep Track Capital, LP, based on Form 13F filings with the SEC.

News

Stay updated on Deep Track Capital, LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email